High Performance Liquid Chromatographic Method For Determination Of Garenoxacin Mesylate In Pharmaceutical Dosage Form | 4623
ISSN: 2155-952X

Journal of Biotechnology & Biomaterials
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

High performance liquid chromatographic method for determination of garenoxacin mesylate in pharmaceutical dosage form

3rd World Congress on Biotechnology

G. N. Supriya, Ravi Vital Kandisa and B.V.V. Ravi Kumar

Posters: Agrotechnol

DOI: 10.4172/2155-952X.S1.020

A simple and rapid HPLC method was developed for the determination of Garenoxacin mesylate, in pharmaceutical dosage form. An Agilent 1100 series HPLC with DAD Detection and column thermostat was used for the proposed method. Chromatographic separation was achieved on a YMC Pack Pro; C8(150 x 4.5 mm, 5μm) column with mobile phase containing buffer (1.36g KH2 PO4 in 1000ml water, 1ml TEA, pH 4.5?0.05 with OPA): acetonitrile (75:25%, v/v) at a flow rate of 1.0 ml/min. The run time was 6 minutes. The column temperature was maintained at 10? C.Diode array detection and quantification of Garenoxacin was carried out at 279nm.The drug shows linearity in the concentration range of 10-160 μg/ml with a correlation co-efficient of 0.9993.The developed method was validated for specificity, linearity, accuracy, precision (system and method),solution stability and system suitability. Specificity of the method was evaluated with respect to identification, placebo interference and known impurity interference. The proposed method was used successfully for determination of Garenoxacin mesylate in tablet dosage form and can be further applied for bioavailability and pharmacokinetics studies.